NW Medical Cannabis Research

04/01/2025

In an effort to stay true to the purpose of this page, which is to present a fair balance regarding cannabis, I have to share this new study from the ACC. This isn’t the type of study I enjoy sharing, but it's something everyone should know about to weigh the risk vs. benefits. Personally, I am a mid-50-year-old man and have noticed tachycardia when using cannabis for sleep. While using any form of cannabis for sleep, I commonly wake up with multiple warnings from my smart watch, which I wear 24/7 to monitor my vitals, that my heart BPM has been >100 for >10 min while inactive. This is called tachycardia. I have also used a 2-lead ECG and watched the sinus rhythm of my heart during these episodes, and it bounces around, not in a normal manner. My resting heart rate is generally around 65-75. Typically, it goes away after about 1-2 hours, and longer if I consumed an edible. This study was just published in May 2025.

Cannabis Users Face Substantially Higher Risk of Heart Attack As ma*****na use increases, so does evidence showing it harms the heart Mar 18, 2025 Font Size A A A Contact: Nicole Napoli, nnapoli@acc.org, WASHINGTON (Mar 18, 2025) - Ma*****na is now legal in many places, but is it safe? Two new studi...

02/16/2025

This is so spot on…another thing cannabis is used extensively for sleep and pain. Problem…similar to pills, you eventually develop tolerance and doesn’t work. I recommend taking a “drug holiday” and rotate what you use for sleep whether it is cannabis, benedril, Zolpidem, Melatonin, etc. As Dr Hascom discusses sleep hygiene is critical. You will never get ahold of chronic pain w/o sleep. If you’re a chronic pain patient you will likely notice your pain scores going up when you are sleep deprived.

12/23/2024

We build tolerances to numberous pharmaceuticals and cannabis is no different. Consider a washout (of course after the holidays 🎄or whenever the time is right) and I think you will be pleasantly suprised.

If you've been consuming w**d for a while, you've probably developed a high tolerance along the way. Here's how to reset it and keep it from happening again.

11/25/2024

Dr. Ethan Russo, a renowned neurologist and cannabis expert, has authored numerous peer-reviewed studies on cannabinoids. A pioneer in the field, he has extensively researched the "entourage effects" of cannabis. Notably, his work includes the publication "Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects" in the British Journal of Pharmacology (2011).

Dr Ethan Russo has been involved in cannabis research for many years. He dispels some of the myths and talks about recent breakthroughs in the treatment of a...

11/17/2024

“A sleepy cannabis constituent: cannabinol and its active metabolite influence sleep architecture “ - American College of Neuropsychopharmacology 2024

“This study shows CBN affects sleep using objective sleep measures and suggests an active metabolite may contribute to its hypnotic action.”

https://www.nature.com/articles/s41386-024-02018-7

11/09/2024

Date: July 31, 2024
Source: Washington State University

Summary:
A lesser-known cannabinoid that is gaining in popularity Cannabigerol (CBG) effectively reduced anxiety in a clinical trial without the intoxication typically associated with whole plant cannabis. It may even have some memory enhancing effects, according to a new study. For the study, researchers conducted the first human clinical trial investigating the acute effects of CBG on anxiety, stress and mood. The research revealed that 20 mg of hemp-derived CBG significantly reduced feelings of anxiety at 20, 45 and 60 minutes after ingestion compared to a placebo.

A lesser-known cannabinoid that is gaining in popularity Cannabigerol (CBG) effectively reduced anxiety in a clinical trial without the intoxication typically associated with whole plant cannabis. It may even have some memory enhancing effects, according to a new study. For the study, researchers co...

12/05/2020

Ma*****na Opportunity Reinvestment and Expungement Act of 2019 or the MORE Act of 2019 was approved in House of Representatives on Dec 3rd. Goes to Senate next which will likely be blocked but this is progress.

This bill decriminalizes ma*****na.

Specifically, it removes ma*****na from the list of scheduled substances under the Controlled Substances Act and eliminates criminal penalties for an individual who manufactures, distributes, or possesses ma*****na.

The bill also makes other changes, including the following:

replaces statutory references to ma*****na and ma*****na with cannabis, requires the Bureau of Labor Statistics to regularly publish demographic data on cannabis business owners and employees, establishes a trust fund to support various programs and services for individuals and businesses in communities impacted by the war on drugs, imposes a 5% tax on cannabis products and requires revenues to be deposited into the trust fund, makes Small Business Administration loans and services available to entities that are cannabis-related legitimate businesses or service providers, prohibits the denial of federal public benefits to a person on the basis of certain cannabis-related conduct or convictions, prohibits the denial of benefits and protections under immigration laws on the basis of a cannabis-related event (e.g., conduct or a conviction), establishes a process to expunge convictions and conduct sentencing review hearings related to federal cannabis offenses, and directs the Government Accountability Office to study the societal impact of cannabis legalization.

To decriminalize and deschedule cannabis, to provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide for expungement of certain cannabis offenses, and for other purposes.

01/07/2020

43672361-Cannabis-Pain-and-Sleep-Lessons-from-Therapeutic-Clinical-Trials-of-Sativex-a-Cannabis-Based-Medicine

12/25/2019

12/20/2019

Questions and answers about FDA regulation of cannabis and cannabis-derived products

12/14/2019

Cannabinoid hyperemesis syndrome (CHS) is a relatively new phenomenon stumping the medical world. Persons with CHS are cannabis users who experience cyclic nausea and vomiting and abdominal pain that can lead to dehydration and being malnourished.

11/21/2019

An interesting review of 47 CBD products that were tested here in WA from a number of sources. Nice piece from .

Leafly tested dozens of CBD products to see how the results stack up to what’s on the label.